2024 TTM Capital Summit Was Successfully Held In Yangtze River Pharmaceutical Group, Taizhou Jan.05.2025
TTM Capital was rated as one of the TOP 50 Early-Stage Venture Capital Institutions in China Dec.08.2023
TTM Capital was awarded two honors by China Bridge: China's Best Return Venture Capital Institution Jan.18.2024
TTM·Family | ALLYRNA Completes Nearly USD 10 Million Seed Round Capital Raising, Laying a Solid Foundation for R&D in Oncology Therapy and Radiosensitizers Aug.19.2025
TTM・Family | Zenitar Secures Nearly 400 Million CNY in Series B+ Capital Raising, Focusing on Advancing Multiple Global Competitive Innovative Drugs into Pivotal Clinical Stages Aug.08.2025
